Marillion Pharmaceuticals licenses Bracco Imaging's novel targetted prostate and breast cancer treatments

Published on Monday 24 November 2008 - 18:12

Summary :
Braccos treatment for hormone-resistant prostate and advanced (metastatic) breast cancers has unique targeting capability that enables it to home in on tumour cells and spare normal tissues.
Read more

Information source

Medical Technology Business Europe

http://www.mtbeurope.info

Website description
News of developments in medical technology - from the wide range of medical electronic devices, diagnostic imaging and information technology to cutting-edge nanotechnology

Articles published on this website : 0 / 7 days - 1 / 30 days

First UK prostate patient treated with RapidArc radiotherapy New catheter-less technique may ease pain and discomfort Website to help prostate cancer specialists make better bioMrieux to develop non-invasive test for prostate cancer NICE clarification boosts UK treatment options for prostate

Other articles published on other websites on the same day

Oily fish may boost prostate cancer survival http://foodconsumer.org/ The Value of Mammograms: Think Again http://blog.newsweek.com/ The Roundup Of Vitamin Benefits http://www.emaxhealth.com/ CIBC world markets is local 'Mo Money' leader http://network.nationalpost.com/ NCCAM: the not-even-wrong agency [denialism blog] http://www.scienceblogs.com/ Health News: Birmingham Prostate Clinic introduces 10-minute PSA test http://www.birminghampost.net/ CyberKnife Center of Miami Participates in Caribbean Association of Neurosurgeons 35th Annual Conference http://www.caymanmama.com/ Age Alone Should Not Deter ADT Use http://www.renalandurologynews.com/ Urodynamix Presents First Data on Use of NIRS and Transurethral Microwave Therapy at the 26th World Congress of Endourology Conference http://www.marketwire.com/ Correlation between dosimetric effect and intrafraction motion during prostate treatments delivered with helical tomotherapy http://medicalphysicsweb.org/